Market Overview

KEMET Reports Preliminary Fiscal 2019 First Quarter Results

Share:
  • Increasing fiscal year annual forecast to a range of 11.0% to 13.0% revenue growth over prior fiscal year
  • Quarterly net sales of $327.6 million up 3.0% versus prior quarter
  • Tenth consecutive quarter over quarter revenue growth
  • GAAP Gross margin of 28.9% up 180 basis points versus same quarter last year
  • GAAP EPS of $0.60 per diluted share and Non-GAAP Adjusted EPS of $0.55 per diluted share

FORT LAUDERDALE, Fla., July 25, 2018 (GLOBE NEWSWIRE) -- KEMET Corporation ("KEMET" or the "Company") (NYSE:KEM), a leading global supplier of passive electronic components, today reported preliminary results for its first fiscal quarter ended June 30, 2018.

Net sales of $327.6 million for the quarter ended June 30, 2018 increased $9.5 million, or 3.0%, from net sales of $318.1 million for the prior quarter ended March 31, 2018. Net sales increased $53.7 million, or 19.6% from net sales of $273.9 million for the quarter ended June 30, 2017.

"We started the fiscal year strong with mix, shipments, and orders exceeding expectations, as well as some new capacity coming online. This is the tenth consecutive quarter of revenue growth, quarter over quarter, and our view looking into the next quarter is that we could see another 2.0% to 4.0% revenue growth for the September quarter over June. As a result, we have revised our full fiscal year revenue growth forecast over last fiscal year to a range of 11.0% to 13.0%, up from 4.0% to 6.0%", stated Per Loof, the Company's Chief Executive Officer. "We continue to believe that this is a market trend which has been further impacted by various actions taken by competitors resulting in even higher demand for our products," continued Loof.

U.S. GAAP net income was $35.2 million or $0.60 per diluted share for the quarter ended June 30, 2018, compared to U.S. GAAP net income of $2.3 million or $0.04 per diluted share for the quarter ended March 31, 2018. For the quarter ended June 30, 2017, the Company reported a U.S. GAAP net income of $220.4 million or $3.82 per diluted share. Net income for the quarter ended June 30, 2017 included a $75.4 million gain on KEMET's equity investment in TOKIN related to the sale of TOKIN's electro-mechanical devices ("EMD") business and a $135.6 million gain on the acquisition of TOKIN.

Non-U.S. GAAP adjusted net income was $32.5 million or $0.55 per diluted share for the quarter ended June 30, 2018, compared to non-U.S. GAAP adjusted net income of $26.2 million or $0.44 per diluted share for the quarter ended March 31, 2018. For the quarter ended June 30, 2017, the Company reported non-U.S. GAAP adjusted net income of $19.1 million or $0.33 per diluted share.

Net income (loss) for the quarters ended June 30, 2018, March 31, 2018 and June 30, 2017 include various items affecting comparability as denoted in the U.S. GAAP to Non-U.S. GAAP reconciliation table included hereafter.

About KEMET

The Company's common stock is listed on the NYSE under the ticker symbol "KEM" (NYSE:KEM).  At the Investor Relations section of our web site at http://www.kemet.com/IR, users may subscribe to KEMET news releases and find additional information about our Company.  KEMET offers our customers the broadest selection of capacitor technologies in the industry, along with an expanding range of electromechanical devices, electromagnetic compatibility solutions and supercapacitors.  Our vision is to be the preferred supplier of electronic component solutions demanding the highest standards of quality, delivery and service.  Additional information about KEMET can be found at http://www.kemet.com.

Quiet Period

Beginning October 1, 2018, we will observe a quiet period during which the information provided in this news release and quarterly report on Form 10-Q will no longer constitute our current expectations. During the quiet period, this information should be considered to be historical, applying prior to the quiet period only and not subject to update by management. The quiet period will extend until the day when our next quarterly earnings release is published.

Cautionary Statement on Forward-Looking Statements

Certain statements included herein contain forward-looking statements within the meaning of federal securities laws about the Company's financial condition and results of operations that are based on management's current expectations, estimates and projections about the markets, in which the Company operates, as well as management's beliefs and assumptions. Words such as "expects," "anticipates," "believes," "estimates" or other similar expressions and future or conditional verbs such as "will," "should," "would," and  "could" are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in, or implied by, such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's judgment only as of the date hereof. The Company undertakes no obligation to update publicly any of these forward-looking statements to reflect new information, future events or otherwise.

Factors that may cause actual outcomes and results to differ materially from those expressed in, or implied by, these forward-looking statements include, but are not necessarily limited to the following: (i) adverse economic conditions could impact our ability to realize operating plans if the demand for our products declines, and such conditions could adversely affect our liquidity and ability to continue to operate and could cause a write down of long-lived assets or goodwill; (ii) an increase in the cost or a decrease in the availability of our principal or single-sourced purchased raw materials; (iii) changes in the competitive environment; (iv) uncertainty of the timing of customer product qualifications in heavily regulated industries; (v) economic, political, or regulatory changes in the countries in which we operate; (vi) difficulties, delays, or unexpected costs in completing the restructuring plans; (vii) acquisitions and other strategic transactions expose us to a variety of risks; (viii) acquisition of TOKIN may not achieve all of the anticipated results; (ix) our business could be negatively impacted by increased regulatory scrutiny and litigation; (x) difficulties associated with retaining, attracting, and training effective employees and management; (xi) the need to develop innovative products to maintain customer relationships and offset potential price erosion in older products; (xii) exposure to claims alleging product defects; (xiii) the impact of laws and regulations that apply to our business, including those relating to environmental matters and cyber security; (xiv) the impact of international laws relating to trade, export controls and foreign corrupt practices; (xv) changes impacting international trade and corporate tax provisions related to the global manufacturing and sales of our products may have an adverse effect on our financial condition and results of operations; (xvi) volatility of financial and credit markets affecting our access to capital; (xvii) the need to reduce the total costs of our products to remain competitive; (xviii) potential limitation on the use of net operating losses to offset possible future taxable income; (xix) restrictions in our debt agreements that could limit our flexibility in operating our business; (xx) disruption to our information technology systems to function properly or control unauthorized access to our systems may cause business disruptions; (xxi) economic and demographic experience for pension and other post-retirement benefit plans could be less favorable than our assumptions; (xxii) fluctuation in distributor sales could adversely affect our results of operations, (xxiii) earthquakes and other natural disasters could disrupt our operations and have a material adverse effect on our financial condition and results of operations, (xxiv) volatility in our stock price.


 
KEMET CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Operations
(Amounts in thousands, except per share data)
(Unaudited)
 
  Quarters Ended June 30,
  2018   2017
Net sales (1) $ 327,616     $ 273,946  
Operating costs and expenses:      
Cost of sales (1) 232,795     199,829  
Selling, general and administrative expenses 48,542     35,631  
Research and development (1) 10,688     9,247  
Restructuring charges (96 )   1,613  
(Gain) loss on write down and disposal of long-lived assets 511     19  
Total operating costs and expenses (1) 292,440     246,339  
    Operating income (loss) (1) 35,176     27,607  
Non-operating (income) expense:      
Interest income (378 )   (66 )
Interest expense 7,036     10,960  
Acquisition (gain) loss     (135,588 )
Other (income) expense, net (11,371 )   6,139  
    Income (loss) before income taxes and equity income (loss) from equity method investments (1) 39,889     146,162  
Income tax expense (benefit) (1) 4,600     1,140  
    Income (loss) before equity income (loss) from equity method investments (1) 35,289     145,022  
Equity income (loss) from equity method investments (69 )   75,417  
      Net income (loss) (1) $ 35,220     $ 220,439  
       
Net income (loss) per basic share (1) $ 0.61     $ 4.65  
Net income (loss) per diluted share $ 0.60     $ 3.82  
       
Weighted-average shares outstanding:      
Basic 57,339     47,381  
Diluted 59,038     57,731  

_________________
(1) Quarter ended June 30, 2017 adjusted due to the adoption of ASC 606, Revenue from Contracts with Customers ("ASC 606").


 
KEMET CORPORATION AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(Amounts in thousands, except per share data)
(Unaudited)
 
  June 30, 2018   March 31, 2018
ASSETS      
Current assets:      
Cash and cash equivalents $ 244,648     $ 286,846  
Accounts receivable, net (1) 160,731     146,561  
Inventories, net 205,956     204,386  
Prepaid expenses and other current assets 39,383     41,160  
Total current assets  (1) 650,718     678,953  
Property, plant and equipment, net 397,123     405,316  
Goodwill 40,294     40,294  
Intangible assets, net 57,297     59,907  
Equity method investments 11,212     12,016  
Deferred income taxes 11,441     13,837  
Other assets (1) 10,977     12,600  
Total assets (1) $ 1,179,062     $ 1,222,923  
LIABILITIES AND STOCKHOLDERS' EQUITY      
Current liabilities:      
Current portion of long-term debt $ 20,412     $ 20,540  
Accounts payable 143,125     139,989  
Accrued expenses (1) 98,315     125,119  
Income taxes payable 5,301     2,010  
Total current liabilities (1) 267,153     287,658  
Long-term debt 299,811     304,083  
Other non-current obligations(1) 129,034     152,249  
Deferred income taxes (1) 14,090     15,058  
Total liabilities (1) 710,088     759,048  
Stockholders' equity:      
Preferred stock, par value $0.01, authorized 10,000 shares, none issued      
Common stock, par value $0.01, authorized 175,000 shares, issued 57,347 and
56,641 shares at June 30, 2018 and March 31, 2018, respectively
573     566  
Additional paid-in capital 461,261     462,737  
Retained earnings (deficit) (1) 38,590     3,370  
Accumulated other comprehensive income (loss) (1) (31,450 )   (2,798 )
Total stockholders' equity (1) 468,974     463,875  
Total liabilities and stockholders' equity  (1) $ 1,179,062     $ 1,222,923  

_________________
(1) Year ended March 31, 2018 adjusted due to the adoption of ASC 606.


   
KEMET CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
(Amounts in thousands)
(Unaudited)
   
  Quarters Ended June 30,
  2018   2017
Net income (loss) (1) $ 35,220     $ 220,439  
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Depreciation and amortization (1) 13,097     13,056  
Equity (income) loss from equity method investments 69     (75,417 )
Acquisition (gain) loss     (135,588 )
Non-cash debt and financing costs 229     460  
(Gain) loss on early extinguishment of debt     486  
Stock-based compensation expense 4,060     1,101  
Rent receivable 3,077      
(Gain) loss on write down and disposal of long-lived assets 511     19  
Pension and other post-retirement benefits 1,274     687  
Change in deferred income taxes 951     (147 )
Change in operating assets (1) (24,520 )   24,073  
Change in operating liabilities (1) (49,330 )   (39,039 )
Other (1) (488 )   (88 )
Net cash provided by (used in) operating activities (1) (15,850 )   10,042  
Investing activities:      
Capital expenditures (16,021 )   (7,298 )
Acquisitions, net of cash received     167,129  
Proceeds from dividend 772      
Net cash provided by (used in) investing activities (15,249 )   159,831  
Financing activities:      
Payments on revolving line of credit     (33,881 )
Payment of long-term debt (4,313 )   (353,000 )
Proceeds from issuance of debt     329,659  
Proceeds from exercise of stock options 275     2,063  
Net cash provided by (used in) financing activities (4,038 )   (55,159 )
Net increase (decrease) in cash and cash equivalents (35,137 )   114,714  
Effect of foreign currency fluctuations on cash (1) (7,061 )   1,156  
Cash and cash equivalents at beginning of fiscal period 287,725     109,774  
Cash and cash equivalents at end of fiscal period $ 244,648     $ 225,644  

_________________
(1) Quarter ended June 30, 2017 adjusted due to the adoption of ASC 606.


Non-U.S. GAAP Financial Measures

The Company utilizes certain Non-U.S. GAAP financial measures, including "Adjusted gross margin", "Adjusted operating income (loss)", "Adjusted net income (loss)", "Adjusted net income (loss) per share" and "Adjusted EBITDA".  Management believes that investors may find it useful to review the Company's financial results as adjusted to exclude items as determined by management as further described below.

Adjusted Gross Margin

Adjusted gross margin represents net sales less cost of sales excluding adjustments which are outlined in the quantitative reconciliation provided below.  Management uses adjusted gross margin to facilitate our analysis and understanding of our business operations by excluding the items outlined in the quantitative reconciliation provided below which might otherwise make comparisons of our ongoing business with prior periods more difficult and obscure trends in ongoing operations. The Company believes that adjusted gross margin is useful to investors because it provides a supplemental way to understand the underlying operating performance of the Company.  Adjusted gross margin should not be considered as an alternative to gross margin or any other performance measure derived in accordance with U.S. GAAP.

The following table provides reconciliation from U.S. GAAP Gross margin to Non-U.S. GAAP Adjusted gross margin (amounts in thousands, except percentages):

  Quarters Ended
  (Unaudited)
  June 30, 2018   March 31, 2018   June 30, 2017
Net sales (1) $ 327,616     $ 318,091     $ 273,946  
Cost of sales (1) 232,795     229,963     199,829  
Gross margin (U.S. GAAP) (1) 94,821     88,128     74,117  
Gross margin as a % of net sales 28.9 %   27.7 %   27.1 %
Non-U.S. GAAP adjustments:          
Stock-based compensation expense 589     465     310  
Plant start-up costs 753     929      
Adjusted gross margin (non-GAAP) $ 96,163     $ 89,522     $ 74,427  
Adjusted gross margin as a % of net sales (non-GAAP) 29.4 %   28.1 %   27.2 %

_________________
(1) Quarters ended March 31, 2018 and June 30, 2017 adjusted due to the adoption of ASC 606.


Adjusted Operating Income (Loss)

Adjusted operating income (loss) represents operating income (loss), excluding adjustments which are outlined in the quantitative reconciliation provided below. We use Adjusted operating income (loss) to facilitate our analysis and understanding of our business operations by excluding the items outlined in the quantitative reconciliation provided below, which might otherwise make comparisons of our ongoing business with prior periods more difficult and obscure trends in ongoing operations. The Company believes that Adjusted operating income (loss) is useful to investors to provide a supplemental way to understand our underlying operating performance and allows investors to monitor and understand changes in our ability to generate income from ongoing business operations. Adjusted operating income (loss) should not be considered as an alternative to operating income (loss) or any other performance measure derived in accordance with U.S. GAAP.

Adjusted operating income (loss) is calculated as follows (amounts in thousands):

  Quarters Ended
  (Unaudited)
  June 30, 2018   March 31, 2018   June 30, 2017
Operating income (loss) (U.S. GAAP) (1) $ 35,176     $ 21,646     $ 27,607  
Adjustments:          
ERP integration/IT transition costs 1,650     80      
Stock-based compensation expense 4,060     2,820     1,101  
Restructuring charges (96 )   8,307     1,613  
Legal expenses/fines related to antitrust class actions 1,286     1,738     1,141  
(Gain) loss on write down and disposal of long-lived assets 511     (70 )   19  
Plant start-up costs 753     929      
Adjusted operating income (loss) (non-GAAP) (1) $ 43,340     $ 35,450     $ 31,481  

_________________
(1) Quarters ended March 31, 2018 and June 30, 2017 adjusted due to the adoption of ASC 606.


Adjusted Net Income (Loss) and Adjusted Net Income (Loss) Per Share

"Adjusted net income (loss)" and "Adjusted net income (loss) per basic and diluted share" represent net income (loss) and net income (loss) per basic and diluted share excluding adjustments which are outlined in the quantitative reconciliation provided below.  The Company believes that these Non-U.S. GAAP financial measures are useful to investors because they provide a supplemental way to understand the underlying operating performance of the Company and allows investors to monitor and understand changes in our ability to generate income from ongoing business operations.  Management uses these Non-U.S. GAAP financial measures to evaluate operating performance by excluding the items outlined in the quantitative reconciliation provided earlier in this presentation which might otherwise make comparisons of our ongoing business with prior periods more difficult and obscure trends in ongoing operations. Non-U.S. GAAP financial measures should not be considered as an alternative to net income (loss), operating income (loss) or any other performance measures derived in accordance with U.S. GAAP.

The following table provides reconciliation from U.S. GAAP net income (loss) to Non-U.S. GAAP Adjusted net income (loss) (amounts in thousands, except per share data):

  Quarters Ended
  (Unaudited)
  June 30, 2018   March 31, 2018   June 30, 2017
U.S. GAAP  
Net sales (1) $ 327,616     $ 318,091     $ 273,946  
Net income (loss) (1) $ 35,220     $ 2,280     $ 220,439  
           
Net income (loss) per basic share (1) $ 0.61     $ 0.04     $ 4.65  
Net income (loss) per diluted share $ 0.60     $ 0.04     $ 3.82  
           
Non-U.S. GAAP          
Net income (loss) (1) $ 35,220     $ 2,280     $ 220,439  
Adjustments:          
Net foreign exchange (gain) loss (7,521 )   3,972     5,043  
ERP integration/IT transition costs 1,650     80      
Stock-based compensation expense 4,060     2,820     1,101  
Restructuring charges (96 )   8,307     1,613  
Research and development grant reimbursement (4,087 )        
Legal expenses/fines related to antitrust class actions 1,248     1,095     1,141  
Amortization included in interest expense 229     647     460  
Acquisition (gain) loss     6,303     (135,588 )
Equity (income) loss from equity method investments 69     (313 )   (75,417 )
(Gain) loss on write down and disposal of long-lived assets 511     (70 )   19  
Plant start-up costs 753     929      
(Gain) loss on early extinguishment of debt         486  
Income tax effect of non-U.S. GAAP adjustments 451     156     (222 )
Adjusted net income (loss) (non-GAAP) (1) $ 32,487     $ 26,206     $ 19,075  
Adjusted net income (loss) per basic share (non-GAAP) $ 0.57     $ 0.46     $ 0.40  
Adjusted net income (loss) per diluted share (non-GAAP) $ 0.55     $ 0.44     $ 0.33  
Weighted average shares outstanding:          
Weighted average shares-basic 57,339     57,025     47,381  
Weighted average shares-diluted 59,038     59,063     57,731  

_________________
(1) Quarters ended March 31, 2018 and June 30, 2017 adjusted due to the adoption of ASC 606.


Adjusted EBITDA

Adjusted EBITDA represents net income (loss) before net interest expense, income tax expense (benefit), and depreciation and amortization expense, adjusted to exclude certain items which are outlined in the quantitative reconciliation provided herein.  We use Adjusted EBITDA to monitor and evaluate our operating performance and to facilitate internal and external comparisons of the historical operating performance of our business.  We present Adjusted EBITDA as a supplemental measure of our performance and ability to service debt.  We also present Adjusted EBITDA because we believe such measure is frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry.

We believe Adjusted EBITDA is an appropriate supplemental measure of debt service capacity because cash expenditures on interest are, by definition, available to pay interest, and tax expense is inversely correlated to interest expense because tax expense goes down as deductible interest expense goes up; depreciation and amortization are non-cash charges. The other adjustments to arrive at Adjusted EBITDA are excluded in order to better reflect our continuing operations.

In evaluating Adjusted EBITDA, you should be aware that in the future we may incur expenses similar to the adjustments noted below.  Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these types of adjustments.  Adjusted EBITDA is not a measurement of our financial performance under U.S. GAAP and should not be considered as an alternative to net income, operating income or any other performance measures derived in accordance with U.S. GAAP or as an alternative to cash flow from operating activities as a measure of our liquidity.

Our Adjusted EBITDA measure has limitations as an analytical tool, and should not be considered in isolation or as a substitute for analysis of our results as reported under U.S. GAAP.  Some of these limitations are:

  • it does not reflect our cash expenditures, future requirements for capital expenditures or contractual commitments;
  • it does not reflect changes in, or cash requirements for, our working capital needs;
  • it does not reflect any income tax expense or benefit, including any potential changes to income tax resulting from The Tax Cuts and Jobs Act enacted on December 22, 2017;
  • it does not reflect the significant interest expense or the cash requirements necessary to service interest or principal payment on our debt;
  • although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and our Adjusted EBITDA measure does not reflect any cash requirements for such replacements;
  • it is not adjusted for all non-cash income or expense items that are reflected in our statements of cash flows;
  • it does not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations;
  • it does not reflect limitations on or costs related to transferring earnings from our subsidiaries to us; and
  • other companies in our industry may calculate this measure differently than we do, limiting its usefulness as a comparative measure.

Because of these limitations, Adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business or as a measure of cash that will be available to us to meet our obligations.  You should compensate for these limitations by relying primarily on our U.S. GAAP results and using Adjusted EBITDA as supplementary information.

The following table provides a reconciliation from U.S. GAAP net income (loss) to Adjusted EBITDA (amounts in thousands):

  Quarters Ended
  (Unaudited)
  June 30, 2018   March 31, 2018   June 30, 2017
Net income (loss) (U.S. GAAP)(1) $ 35,220     $ 2,280     $ 220,439  
           
Adjustments:          
Interest expense, net 6,658     6,754     10,894  
Income tax expense (benefit) (1) 4,600     3,091     1,140  
Depreciation and amortization(1) 13,096     13,295     12,459  
EBITDA (non-GAAP)(1) 59,574     25,420     244,932  
Excluding the following items:          
Net foreign exchange (gain) loss (7,521 )   3,972     5,043  
Stock-based compensation expense 4,060     2,820     1,101  
ERP integration/IT transition costs 1,650     80      
Restructuring charges (96 )   8,307     1,613  
Research and development grant reimbursement (4,087 )        
Legal expenses/fines related to antitrust class actions 1,248     1,095     1,141  
Acquisition (gain) loss     6,303     (135,588 )
Equity (income) loss from equity method investments 69     (313 )   (75,417 )
(Gain) loss on early extinguishment of debt         486  
(Gain) loss on write down and disposal of long-lived assets 511     (70 )   19  
Plant start-up costs 753     929      
Adjusted EBITDA (non-GAAP) (1) $ 56,161     $ 48,543     $ 43,330  

_________________
(1) Quarters ended March 31, 2018 and June 30, 2017 adjusted due to the adoption of ASC 606.


Contact: William M. Lowe, Jr. Robin Blackwell
  Executive Vice President and Vice President Corporate Communications
  Chief Financial Officer and Investor Relations
  williamlowe@kemet.com robinblackwell@kemet.com
  864-963-6484 954-245-8742

Primary Logo

View Comments and Join the Discussion!